The SELUTION DeNovo Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 3326 participants.

Also called NCT04859985

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 3,326 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04859985
Other papers using this trial's data
  • Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial Circulation, 2026-07-21 DOI, PubMed 42290366, PMC13378755 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria, Czechia, Finland, France, Germany, Italy, Netherlands, Poland, Singapore, Spain, Switzerland, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04859985. Randomized; no masking; primary purpose treatment. Start 2021-05-15 (actual); primary completion 2025-09-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The SELUTION DeNovo Study
Intervention (Device)
SELUTION SLR
Intervention (Device)
DES
Lead sponsor
M.A. Med Alliance S.A. (class: industry)

Record details

Record id
cardio:ct-nct04859985
Content hash
9c3c07424d9d27af47d322f165650c551ec6bf07e58a9c4aef8f2249894f1513